NUVECTIS PHARMA INC (NVCT) Stock Earnings & Estimates
USA - NASDAQ:NVCT - US67080T1088 - Common Stock
6.01 USD
-0.05 (-0.83%)
6.01 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | ||||||
| EBITDA YoY % growth | N/A | N/A | N/A -30.28% | N/A -21.62% | N/A 14.67% | N/A -38.02% | N/A -16.60% | N/A -22.01% | |
| EBIT YoY % growth | -10K | -12.89M -128,800.00% | -19.23M -49.19% | -23M -19.60% | -20M 13.04% | N/A -23.80% | N/A -10.69% | N/A -15.43% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A 58.45% | -1.43 0.48% | -1.11 22.38% | N/A 3.05% | N/A 0.24% | N/A -8.08% |
All data in USD
| Q4 / 25 | |
|---|---|
| EPS Q2Q % growth | -0.28 21.37% |
| Revenue Q2Q % growth | |
| EBITDA Q2Q % growth | -8.16M -37.93% |
| EBIT Q2Q % growth | -7.467M -15.77% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.33 -37.50% | -0.25 | -0.08 | -30.72% |
| Q2 2025 Q2Q % growth | -0.30 -15.38% | -0.26 | -0.04 | -15.34% |
| Q1 2025 Q2Q % growth | -0.27 -8.00% | -0.26 | -0.01 | -4.21% |
| Q4 2024 Q2Q % growth | -0.36 12.20% | -0.26 | -0.10 | -39.50% |
| Q3 2024 Q2Q % growth | -0.24 35.14% | -0.26 | 0.02 | 6.75% |
| Q2 2024 Q2Q % growth | -0.26 31.58% | -0.27 | 0.01 | 1.96% |
| Q1 2024 Q2Q % growth | -0.25 7.41% | -0.40 | 0.15 | 38.21% |
| Q4 2023 Q2Q % growth | -0.41 -4.41% | -0.37 | -0.04 | -10.13% |
| Q3 2023 Q2Q % growth | -0.37 11.90% | -0.35 | -0.02 | -5.96% |
| Q2 2023 Q2Q % growth | -0.38 -35.71% | -0.30 | -0.08 | -27.73% |
| Q1 2023 Q2Q % growth | -0.27 15.62% | -0.45 | 0.18 | 40.02% |
| Q4 2022 Q2Q % growth | 18.19% | -0.39 | % | |
| Q3 2022 Q2Q % growth | -0.42 | -0.28 | -0.14 | -52.51% |
| Q2 2022 Q2Q % growth | -0.28 | -0.24 | -0.04 | -17.65% |
| Q1 2022 Q2Q % growth | -0.32 | -0.23 | -0.09 | -36.40% |
| Q4 2021 Q2Q % growth | -0.48 | -0.87 | 0.39 | 44.64% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 3.77% | 0% | -1.11% |
| Revenue | N/A | N/A | N/A | N/A |